3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
2
Lymphoid
1
CNS
1
Conditions
Brain Neoplasms
1050
Glioblastoma
920
Glioma
603
Central Nervous System Neoplasms
436
Astrocytoma
396
Gliosarcoma
339
Neuroblastoma
325
Oligodendroglioma
255
Neoplasms
181
Medulloblastoma
165
Breast Neoplasms
154
Sarcoma
114
Recurrence
108
Ependymoma
105
Neoplasm Metastasis
95
Meningioma
91
Melanoma
88
Lymphoma
87
Carcinoma, Non-Small-Cell Lung
87
Lung Neoplasms
82
Precursor Cell Lymphoblastic Leukemia-Lymphoma
79
Neurofibromatosis 1
79
Wilms Tumor
75
Osteosarcoma
69
Head and Neck Neoplasms
69
Ovarian Neoplasms
68
Testicular Neoplasms
67
Lymphoma, Non-Hodgkin
67
Burkitt Lymphoma
66
Familial ependymoma
63
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Essential Hypertension
×
CNS
×
Clear all
NCT01022515
2026-02-06
PHEO
University Hospital, Rouen
Phase NA
Completed
60 enrolled